首页/数据集/Number of orphan designations accepted in the U.S. 2003-2025

Number of orphan designations accepted in the U.S. 2003-2025

Statista2026-04-11 收录

孤儿药认定

罕见病药物监管

数据链接：

https://www.statista.com/statistics/373412/number-orphan-designations-accepted-in-the-us/数据链接链接失效反馈

官方服务：

资源简介：

Annual number of accepted orphan designations in the United States from 2003 to 2025

应用场景：

罕见病药物监管

真实世界数据应用

Background: Reference to so-called real-world data is more often made in marketing authorization applications for medicines intended to diagnose, prevent or treat rare diseases compared to more common

NIAID Data Ecosystem20

Additional file 1: of Investigating the landscape of US orphan product approvals

孤儿药审批

罕见病药物监管

Appendix: Approved Orphan Products Dataset. (XLSX 92Â kb)

Figshare2018-10-23 更新10

Withdrawn orphan drug designations.

孤儿药指定撤回

罕见病药物监管

Reasons for and time of withdrawal were not specified in the FDA database.

Figshare2020-04-08 更新00

Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies.

孤儿药认定

生物技术IPO评估

Orphan Drug (OD) legislation has been implemented with regulatory and financial incentives to encourage drug innovation in order to treat rare diseases. This study aims to test whether OD Designations

NBER2017-11-01 更新20

Medicine data: rare disease (orphan) designations

孤儿药认定

罕见疾病药物监管

Information on rare disease (orphan) designations based on applications that have been assessed by the European Medicines Agency's (EMA) Committee for Orphan Medicinal Products (COMP). An orphan de

data.europa10

Number of orphan designations accepted in the U.S. 2003-2025

资源简介：

相关数据集